Post: Kourweogo Seeks Community Leaders’ Support for R21 Malaria Vaccine Rollout

Kourweogo: The Secretary General of Kourweogo province, Harouna Kombassere, chaired an advocacy workshop recently in Bousse to explain strategies for extending the R21 malaria vaccine and to request the support of community leaders for mobilization efforts.

According to Burkina Information Agency, the meeting, held on September 9, 2025, in Bousse, gathered health authorities from the Bousse district, directors and heads of departments, traditional chiefs, and association leaders to discuss the vaccine's extension. Dr. Adeline Dabire/Salou, the chief physician of the Bousse health district, highlighted that malaria remains the leading cause of morbidity and mortality in Burkina Faso, especially among children under five. In Kourweogo, the disease impacts schooling, productivity, and life expectancy.

Dr. Dabire/Salou noted that since August 2025, Burkina Faso has integrated the R21 vaccine into its Expanded Programme on Immunization (EPI), alongside other preventive measures like mosquito nets, seasonal chemoprevention, and indoor spraying. She warned that the new vaccine's introduction could face challenges, such as combating rumors and misinformation, which might cause reluctance or refusal to vaccinate. The security situation also poses a major challenge for implementation.

District officials are urging political, administrative, customary, religious leaders, and local organizations to mobilize collectively. These leaders are expected to act as awareness advocates to build trust and encourage parents to vaccinate their children.

Moussa Zongo, head of the district's expanded vaccination program, provided insights into the vaccine's administration strategy. The R21 vaccine is in liquid form, packaged in a 1 ml bottle, offering two doses of 0.5 ml each. Without preservatives, an opened bottle must be used within 6 hours. The target group for the vaccine includes children aged 0 to 23 months, following a four-dose schedule: three primary doses at a minimum interval of four weeks, and a booster dose eight months after the third dose. There are no contraindications except for proven hypersensitivity, and vaccination should be postponed if the child is ill.

Harouna Kombassere emphasized that the malaria vaccine's introduction into the routine vaccination program is a significant innovation, enhancing other preventive measures. Participants at the workshop called for active engagement to dispel doubts, reassure parents, and promote widespread vaccine uptake.

BII Unveils $6.7 Billion Equity Strategy for Africa in Nairobi

Nairobi:British International Investment (BII), the UK development finance institution, has announced a significant new strategy in Nairobi, focusing on investing $6.7 billion in equity across Africa from 2026 to 2031. This initiative aims to attract …

COP31 Scheduled for November 2026 in Antalya, Türkiye

Antalya:The 31st Conference of the Parties to the UN Framework Convention on Climate Change is set to take place from 9 to 20 November 2026 in Antalya, Türkiye. This global gathering aims to address the accelerating climate crisis as nations work towa…

First Simandou Mining Summit Draws Over 1,000 Delegates to Conakry

Conakry:Guinea is hosting the inaugural Simandou Mining Summit in Conakry from November 11 to 14. The event, themed “The Mining Industry A Catalyst for Economic Sovereignty,” is organized by the Simandou Strategic Committee in collaboration with the M…

Biovéa Biomass Power Plant Inaugurated in Ayébo, Ivory Coast

Ayébo:The 46 MW Biovéa Énergie biomass power plant was inaugurated in Ayébo, located in the Aboisso sub-prefecture of the Sud-Comoé region. The inauguration ceremony, held on November 5, was attended by the Minister of Mines, Petroleum and Energy, Mam…

Ethiopia’s GDP Reaches $210.7 Billion Following Rebasing

Addis Ababa:Ethiopia’s Finance Minister, Fitsum Assefa, has announced the results of the GDP rebasing with the Ethiopian fiscal year 2017 (2024/25) as the new base year. The announcement was made in Addis Ababa on November 4.

According to Africa New…